These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 14982757)
1. Mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant gram-positive bacteria. Ruzin A; Singh G; Severin A; Yang Y; Dushin RG; Sutherland AG; Minnick A; Greenstein M; May MK; Shlaes DM; Bradford PA Antimicrob Agents Chemother; 2004 Mar; 48(3):728-38. PubMed ID: 14982757 [TBL] [Abstract][Full Text] [Related]
2. Mannopeptimycins, new cyclic glycopeptide antibiotics produced by Streptomyces hygroscopicus LL-AC98: antibacterial and mechanistic activities. Singh MP; Petersen PJ; Weiss WJ; Janso JE; Luckman SW; Lenoy EB; Bradford PA; Testa RT; Greenstein M Antimicrob Agents Chemother; 2003 Jan; 47(1):62-9. PubMed ID: 12499170 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of transglycosylation involved in bacterial peptidoglycan synthesis. Goldman RC; Gange D Curr Med Chem; 2000 Aug; 7(8):801-20. PubMed ID: 10828288 [TBL] [Abstract][Full Text] [Related]
4. Mannopeptimycins, a novel class of glycopeptide antibiotics active against gram-positive bacteria. He H Appl Microbiol Biotechnol; 2005 Jun; 67(4):444-52. PubMed ID: 15702316 [TBL] [Abstract][Full Text] [Related]
5. Mode of action of beta-lactam antibiotics. Tipper DJ Pharmacol Ther; 1985; 27(1):1-35. PubMed ID: 3889939 [No Abstract] [Full Text] [Related]
6. In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria. Ueda Y; Sunagawa M Antimicrob Agents Chemother; 2003 Aug; 47(8):2471-80. PubMed ID: 12878507 [TBL] [Abstract][Full Text] [Related]
7. Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus. Moreira B; Boyle-Vavra S; deJonge BL; Daum RS Antimicrob Agents Chemother; 1997 Aug; 41(8):1788-93. PubMed ID: 9257762 [TBL] [Abstract][Full Text] [Related]
8. In vitro and bactericidal activities of ABT-492, a novel fluoroquinolone, against Gram-positive and Gram-negative organisms. Almer LS; Hoffrage JB; Keller EL; Flamm RK; Shortridge VD Antimicrob Agents Chemother; 2004 Jul; 48(7):2771-7. PubMed ID: 15215148 [TBL] [Abstract][Full Text] [Related]
9. Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrate. Chen L; Walker D; Sun B; Hu Y; Walker S; Kahne D Proc Natl Acad Sci U S A; 2003 May; 100(10):5658-63. PubMed ID: 12714684 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of NB2001 and NB2030, novel antibacterial agents activated by beta-lactamases. Stone GW; Zhang Q; Castillo R; Doppalapudi VR; Bueno AR; Lee JY; Li Q; Sergeeva M; Khambatta G; Georgopapadakou NH Antimicrob Agents Chemother; 2004 Feb; 48(2):477-83. PubMed ID: 14742198 [TBL] [Abstract][Full Text] [Related]
11. High-throughput screen for inhibitors of transglycosylase and/or transpeptidase activities of Escherichia coli penicillin binding protein 1b. Chandrakala B; Shandil RK; Mehra U; Ravishankar S; Kaur P; Usha V; Joe B; deSousa SM Antimicrob Agents Chemother; 2004 Jan; 48(1):30-40. PubMed ID: 14693515 [TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activities of AC98-6446, a novel semisynthetic glycopeptide derivative of the natural product mannopeptimycin alpha, and other antimicrobial agents against gram-positive clinical isolates. Petersen PJ; Wang TZ; Dushin RG; Bradford PA Antimicrob Agents Chemother; 2004 Mar; 48(3):739-46. PubMed ID: 14982758 [TBL] [Abstract][Full Text] [Related]
13. Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance. Malouin F; Bryan LE Antimicrob Agents Chemother; 1986 Jul; 30(1):1-5. PubMed ID: 3530121 [No Abstract] [Full Text] [Related]
14. In vitro antibacterial activity of KP-736, a new cephem antibiotic. Maejima T; Inoue M; Mitsuhashi S Antimicrob Agents Chemother; 1991 Jan; 35(1):104-10. PubMed ID: 2014964 [TBL] [Abstract][Full Text] [Related]
15. Vancomycin resistance in Enterococcus gallinarum. Vincent S; Minkler P; Bincziewski B; Etter L; Shlaes DM Antimicrob Agents Chemother; 1992 Jul; 36(7):1392-9. PubMed ID: 1510433 [TBL] [Abstract][Full Text] [Related]
16. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall. Fontana R; Altamura M; Arcamone F; Mazzariol A; Morandotti G; Sperning R; Cornaglia G J Antimicrob Chemother; 1998 May; 41(5):513-25. PubMed ID: 9630405 [TBL] [Abstract][Full Text] [Related]
17. Binding of 125I-labeled beta-lactam antibiotics to the penicillin binding proteins of Escherichia coli. Rojo F; Ayala JA; de la Rosa EJ; de Pedro MA; Arán V; Berenguer J; Vázquez D J Antibiot (Tokyo); 1984 Apr; 37(4):389-93. PubMed ID: 6373702 [TBL] [Abstract][Full Text] [Related]